BKAIF Biokey (cayman), Inc.
Fundamentals / CIK 0002108359 / USDBiokey (cayman), Inc. reported $1.61M in total assets through September 30, 2026 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BKAIF in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026-- Sep 30, 2026
-
Operating Income FY 2026-- Operating profit
-
Net Income FY 2026-- GAAP bottom line
-
Diluted EPS FY 2026-- Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$110 Total debt: $1.53M
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Selling, General & Admin | $391K | $250K | $234K | $127K |
| Total Operating Expenses | $391K | $250K | $234K | $127K |
| Operating Income | -$391K | -$250K | -$234K | -$127K |
| EBITDA | -$387K | -$246K | -$229K | -$121K |
| Interest Expense | $44K | $42K | $41K | $36K |
| Income Before Tax | -$398K | -$268K | -$240K | -$145K |
| Net Income | -$398K | -$268K | -$240K | -$145K |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Basic Shares Outstanding | 30.0M | 30.0M | 30.0M | 30.0M |
| Diluted Shares Outstanding | 30.0M | 30.0M | 30.0M | 30.0M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2025-12-31 |
|---|---|---|---|
| Cash & Cash Equivalents | $110 | $4.6K | $2.9K |
| Cash & Short-Term Investments | $110 | $4.6K | $2.9K |
| Total Current Assets | $27K | $59K | $62K |
| Property, Plant & Equipment, Net | $66K | $71K | $81K |
| Total Non-Current Assets | $1.59M | $1.66M | $1.82M |
| Total Assets | $1.61M | $1.72M | $1.88M |
| Deferred Revenue (Current) | $13K | $13K | $13K |
| Total Current Liabilities | $6.31M | $5.96M | $5.50M |
| Total Non-Current Liabilities | $1.26M | $1.32M | $1.46M |
| Total Liabilities | $7.56M | $7.27M | $6.95M |
| Total Debt (incl. Leases) | $1.53M | $1.60M | $1.73M |
| Common Stock | $3.0K | $3.0K | $3.0K |
| Retained Earnings | -$5.95M | -$5.55M | -$5.08M |
| Total Stockholders' Equity | -$5.95M | -$5.55M | -$5.07M |
| Total Equity | -$5.95M | -$5.55M | -$5.07M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net Income | -$398K | -$268K | -$240K | -$145K |
| Depreciation & Amortization | $4.5K | $4.6K | $5.3K | $6.3K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Current Ratio | 0.00x | 0.01x | -- | -- |
| Quick Ratio | 0.00x | 0.00x | -- | -- |